Caladrius Biosciences Inc. (CLBS) upgraded Issued by Wall Street Gurus

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Caladrius Biosciences Inc. (NASDAQ:CLBS) went down by -3.78% from its latest closing price compared to the recent 1-year high of $4.89. The company’s stock price has collected -3.78% of loss in the last five trading sessions. Press Release reported on 03/08/21 that Caladrius Biosciences Announces Orphan Drug Designation for CLBS12 for the Treatment of Buerger’s Disease

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Caladrius Biosciences Inc. (NASDAQ :CLBS) Right Now?

Plus, the 36-month beta value for CLBS is at 1.12. Opinions of the stock are interesting as 2 analysts out of 3 who provided ratings for Caladrius Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


The average price from analysts is $10.00. CLBS currently public float of 46.06M and currently shorts hold a 3.89% ratio of that float. Today, the average trading volume of CLBS was 6.64M shares.

CLBS’s Market Performance

CLBS stocks went down by -3.78% for the week, with a monthly drop of -0.56% and a quarterly performance of 23.61%, while its annual performance rate touched 1.14%. The volatility ratio for the week stands at 6.28% while the volatility levels for the past 30 days are set at 7.54% for Caladrius Biosciences Inc.. The simple moving average for the period of the last 20 days is -10.64% for CLBS stocks with a simple moving average of -6.19% for the last 200 days.

Analysts’ Opinion of CLBS

H.C. Wainwright, on the other hand, stated in their research note that they expect to see CLBS reach a price target of $18.50. The rating they have provided for CLBS stocks is “Buy” according to the report published on November 20th, 2018.

Chardan Capital Markets gave a rating of “Buy” to CLBS, setting the target price at $6.50 in the report published on August 23rd of the previous year.

CLBS Trading at -14.69% from the 50-Day Moving Average

After a stumble in the market that brought CLBS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.60% of loss for the given period.

Volatility was left at 7.54%, however, over the last 30 days, the volatility rate increased by 6.28%, as shares sank -2.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.52% lower at present.

During the last 5 trading sessions, CLBS fell by -3.78%, which changed the moving average for the period of 200-days by -2.73% in comparison to the 20-day moving average, which settled at $1.9895. In addition, Caladrius Biosciences Inc. saw 24.48% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CLBS starting from Davidson Michael H., who purchase 55,525 shares at the price of $1.80 back on Sep 09. After this action, Davidson Michael H. now owns 106,588 shares of Caladrius Biosciences Inc., valued at $99,945 using the latest closing price.

Stock Fundamentals for CLBS

The total capital return value is set at -76.27, while invested capital returns managed to touch -30.08. Equity return is now at value -26.90, with -23.70 for asset returns.

Based on Caladrius Biosciences Inc. (CLBS), the company’s capital structure generated 1.92 points at debt to equity in total, while total debt to capital is 1.88. Total debt to assets is 1.73, with long-term debt to equity ratio resting at 0.78. Finally, the long-term debt to capital ratio is 0.77.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The liquidity ratio also appears to be rather interesting for investors as it stands at 10.08.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.